在晚期子宫内膜癌中克服疾病进展:顺序治疗的临床案例
Amedeo Cefaliello1,2, Angela Grieco2, Roberto Buonaiuto2,3
1Department of Woman, Child and Public Health, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
一个案例研究表明,免疫疗法,特别是 pembrolizumab 和 lenvatinib,在多次先前治疗后,在晚期子宫内膜癌 (EC) 中实现了长期的疾病控制. 这种组合疗法即使在最初的进展后也表现出有效性,为难以治疗的病例提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 妇科瘤学 妇科瘤学
背景情况:
- 晚期子宫内膜癌 (EC) 提出了重大治疗挑战.
- 化学疗法和放射疗法等传统疗法在实现长期疾病控制方面存在局限性.
- 免疫疗法在治疗固体瘤,包括先进的EC瘤方面是一个有前途的前沿.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
相关概念视频
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
